VIRGINIA RETIREMENT SYSTEMS ET Al Makes New Investment in DENTSPLY SIRONA Inc. $XRAY

VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 225,700 shares of the medical instruments supplier’s stock, valued at approximately $2,395,000.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Paradigm Capital Management Inc. NY purchased a new position in DENTSPLY SIRONA in the 2nd quarter worth about $39,775,000. Edmond DE Rothschild Holding S.A. purchased a new stake in DENTSPLY SIRONA during the second quarter valued at about $47,780,000. BlackRock Inc. purchased a new stake in DENTSPLY SIRONA during the second quarter valued at about $283,405,000. Bank of New York Mellon Corp acquired a new position in shares of DENTSPLY SIRONA in the second quarter worth about $16,408,000. Finally, The Manufacturers Life Insurance Company acquired a new position in shares of DENTSPLY SIRONA in the second quarter worth about $1,956,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

XRAY stock opened at $10.50 on Friday. The firm has a 50 day simple moving average of $12.15 and a 200 day simple moving average of $11.62. DENTSPLY SIRONA Inc. has a 52 week low of $9.40 and a 52 week high of $14.76. The stock has a market cap of $2.09 billion, a P/E ratio of -3.82, a P/E/G ratio of 1.36 and a beta of 0.84. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.07 and a current ratio of 1.63.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.17. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The firm had revenue of $898.00 million for the quarter, compared to analyst estimates of $889.93 million. During the same quarter in the prior year, the business earned $0.52 EPS. The company’s revenue for the quarter was down 4.1% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Research analysts anticipate that DENTSPLY SIRONA Inc. will post 1.4 earnings per share for the current fiscal year.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Brian Gladden purchased 9,985 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were acquired at an average cost of $10.02 per share, with a total value of $100,049.70. Following the completion of the purchase, the director owned 61,849 shares of the company’s stock, valued at $619,726.98. The trade was a 19.25% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.46% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on XRAY. Piper Sandler boosted their price target on shares of DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a “neutral” rating in a report on Wednesday, July 29th. Barclays lifted their price objective on shares of DENTSPLY SIRONA from $9.00 to $11.00 and gave the stock an “underweight” rating in a research report on Monday, August 24th. BMO Capital Markets reissued a “market perform” rating and set a $13.00 target price on shares of DENTSPLY SIRONA in a research note on Friday, August 7th. Barrington Research set a $15.00 target price on DENTSPLY SIRONA in a report on Monday, August 10th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research report on Monday, August 3rd. Three equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $13.54.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.